Fetal responses to maternal infusions of angiotensin II

Alfredo J. Perales, Raymond P. Naden, Abbot Laptook, Charles R. Rosenfeld

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

It is unclear whether the fetus is affected by maternal infusions of angiotensin II; therefore we studied maternal and fetal responses (n = 9) to angiotensin II (1.15, 2.29, 11.5 μg/min) infused 5 minutes into the vena cava of chronically instrumented sheep (129 to 137 days of gestation) while monitoring Po2, Pco2, pH heart rate, uterine blood flow, and arterial and umbilical venous pressures. Pregnant sheep demonstrated expected dose-related increases in mean arterial pressure and decreases in uterine blood flow (p < 0.05). Increases in fetal mean arterial pressure also correlated with the maternal dose of angiotensin II (r = 0.77, p < 0.001). Fetal heart rate appeared to increase with 2.29 μg/min; however, bradycardia was observed with 11.5 μg/min (p < 0.05) and was associated with decreased PaO2 , 19.0 ± 1.0 to 14.3 ± 1.4 mm Hg (p, 0.05), increased PaO2 (p < 0.05), and decreased umbilical venous Po2, 31.4 ± 2.3 to 27.0 ± 27.0 ± 1.9 mm Hg. The decreases in Po2 correlated with decreases in uterine blood flow (r = 0.60, p < 0.002, and r = 0.75, p < 0.005, respectively). Nevertheless, changes in fetal mean arterial pressure also occurred in the absence of altered fetal oxygenation; thus decreased uterine blood flow and fetal oxygenation alone cannot explain the fetal cardiovascular responses. It is suggested that angiotensin II or an active metabolite may cross the ovine placenta.

Original languageEnglish (US)
Pages (from-to)195-203
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume154
Issue number1
DOIs
StatePublished - 1986

Fingerprint

Angiotensin II
Mothers
Umbilicus
Sheep
Arterial Pressure
Venae Cavae
Fetal Heart Rate
Venous Pressure
Bradycardia
Fetal Blood
Placenta
Fetus
Heart Rate
Pregnancy

Keywords

  • angiotensin II
  • fetal oxygenation
  • fetus
  • Uterine blood flow

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Fetal responses to maternal infusions of angiotensin II. / Perales, Alfredo J.; Naden, Raymond P.; Laptook, Abbot; Rosenfeld, Charles R.

In: American Journal of Obstetrics and Gynecology, Vol. 154, No. 1, 1986, p. 195-203.

Research output: Contribution to journalArticle

Perales, Alfredo J. ; Naden, Raymond P. ; Laptook, Abbot ; Rosenfeld, Charles R. / Fetal responses to maternal infusions of angiotensin II. In: American Journal of Obstetrics and Gynecology. 1986 ; Vol. 154, No. 1. pp. 195-203.
@article{6db172ad25cb4410aacd73f44a969342,
title = "Fetal responses to maternal infusions of angiotensin II",
abstract = "It is unclear whether the fetus is affected by maternal infusions of angiotensin II; therefore we studied maternal and fetal responses (n = 9) to angiotensin II (1.15, 2.29, 11.5 μg/min) infused 5 minutes into the vena cava of chronically instrumented sheep (129 to 137 days of gestation) while monitoring Po2, Pco2, pH heart rate, uterine blood flow, and arterial and umbilical venous pressures. Pregnant sheep demonstrated expected dose-related increases in mean arterial pressure and decreases in uterine blood flow (p < 0.05). Increases in fetal mean arterial pressure also correlated with the maternal dose of angiotensin II (r = 0.77, p < 0.001). Fetal heart rate appeared to increase with 2.29 μg/min; however, bradycardia was observed with 11.5 μg/min (p < 0.05) and was associated with decreased PaO2 , 19.0 ± 1.0 to 14.3 ± 1.4 mm Hg (p, 0.05), increased PaO2 (p < 0.05), and decreased umbilical venous Po2, 31.4 ± 2.3 to 27.0 ± 27.0 ± 1.9 mm Hg. The decreases in Po2 correlated with decreases in uterine blood flow (r = 0.60, p < 0.002, and r = 0.75, p < 0.005, respectively). Nevertheless, changes in fetal mean arterial pressure also occurred in the absence of altered fetal oxygenation; thus decreased uterine blood flow and fetal oxygenation alone cannot explain the fetal cardiovascular responses. It is suggested that angiotensin II or an active metabolite may cross the ovine placenta.",
keywords = "angiotensin II, fetal oxygenation, fetus, Uterine blood flow",
author = "Perales, {Alfredo J.} and Naden, {Raymond P.} and Abbot Laptook and Rosenfeld, {Charles R.}",
year = "1986",
doi = "10.1016/0002-9378(86)90424-2",
language = "English (US)",
volume = "154",
pages = "195--203",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Fetal responses to maternal infusions of angiotensin II

AU - Perales, Alfredo J.

AU - Naden, Raymond P.

AU - Laptook, Abbot

AU - Rosenfeld, Charles R.

PY - 1986

Y1 - 1986

N2 - It is unclear whether the fetus is affected by maternal infusions of angiotensin II; therefore we studied maternal and fetal responses (n = 9) to angiotensin II (1.15, 2.29, 11.5 μg/min) infused 5 minutes into the vena cava of chronically instrumented sheep (129 to 137 days of gestation) while monitoring Po2, Pco2, pH heart rate, uterine blood flow, and arterial and umbilical venous pressures. Pregnant sheep demonstrated expected dose-related increases in mean arterial pressure and decreases in uterine blood flow (p < 0.05). Increases in fetal mean arterial pressure also correlated with the maternal dose of angiotensin II (r = 0.77, p < 0.001). Fetal heart rate appeared to increase with 2.29 μg/min; however, bradycardia was observed with 11.5 μg/min (p < 0.05) and was associated with decreased PaO2 , 19.0 ± 1.0 to 14.3 ± 1.4 mm Hg (p, 0.05), increased PaO2 (p < 0.05), and decreased umbilical venous Po2, 31.4 ± 2.3 to 27.0 ± 27.0 ± 1.9 mm Hg. The decreases in Po2 correlated with decreases in uterine blood flow (r = 0.60, p < 0.002, and r = 0.75, p < 0.005, respectively). Nevertheless, changes in fetal mean arterial pressure also occurred in the absence of altered fetal oxygenation; thus decreased uterine blood flow and fetal oxygenation alone cannot explain the fetal cardiovascular responses. It is suggested that angiotensin II or an active metabolite may cross the ovine placenta.

AB - It is unclear whether the fetus is affected by maternal infusions of angiotensin II; therefore we studied maternal and fetal responses (n = 9) to angiotensin II (1.15, 2.29, 11.5 μg/min) infused 5 minutes into the vena cava of chronically instrumented sheep (129 to 137 days of gestation) while monitoring Po2, Pco2, pH heart rate, uterine blood flow, and arterial and umbilical venous pressures. Pregnant sheep demonstrated expected dose-related increases in mean arterial pressure and decreases in uterine blood flow (p < 0.05). Increases in fetal mean arterial pressure also correlated with the maternal dose of angiotensin II (r = 0.77, p < 0.001). Fetal heart rate appeared to increase with 2.29 μg/min; however, bradycardia was observed with 11.5 μg/min (p < 0.05) and was associated with decreased PaO2 , 19.0 ± 1.0 to 14.3 ± 1.4 mm Hg (p, 0.05), increased PaO2 (p < 0.05), and decreased umbilical venous Po2, 31.4 ± 2.3 to 27.0 ± 27.0 ± 1.9 mm Hg. The decreases in Po2 correlated with decreases in uterine blood flow (r = 0.60, p < 0.002, and r = 0.75, p < 0.005, respectively). Nevertheless, changes in fetal mean arterial pressure also occurred in the absence of altered fetal oxygenation; thus decreased uterine blood flow and fetal oxygenation alone cannot explain the fetal cardiovascular responses. It is suggested that angiotensin II or an active metabolite may cross the ovine placenta.

KW - angiotensin II

KW - fetal oxygenation

KW - fetus

KW - Uterine blood flow

UR - http://www.scopus.com/inward/record.url?scp=0022651131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022651131&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(86)90424-2

DO - 10.1016/0002-9378(86)90424-2

M3 - Article

C2 - 3946494

AN - SCOPUS:0022651131

VL - 154

SP - 195

EP - 203

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -